Mesenchymal stem cells generate pericytes to promote tumor recurrence via vasculogenesis after stereotactic body radiation therapy.

[1]  M. Fujimiya,et al.  Contextual niche signals towards colorectal tumor progression by mesenchymal stem cell in the mouse xenograft model , 2015, Journal of Gastroenterology.

[2]  Jun Chen,et al.  Mesenchymal stem cells in lung cancer tumor microenvironment: their biological properties, influence on tumor growth and therapeutic implications. , 2014, Cancer letters.

[3]  S. Ergün,et al.  Nestin(+) Tissue-Resident Multipotent Stem Cells Contribute to Tumor Progression by Differentiating into Pericytes and Smooth Muscle Cells Resulting in Blood Vessel Remodeling , 2014, Front. Oncol..

[4]  J. Brown,et al.  Vasculogenesis: a crucial player in the resistance of solid tumours to radiotherapy. , 2014, The British journal of radiology.

[5]  E. Kleinerman,et al.  Blocking SDF-1α/CXCR4 Downregulates PDGF-B and Inhibits Bone Marrow–Derived Pericyte Differentiation and Tumor Vascular Expansion in Ewing Tumors , 2013, Molecular Cancer Therapeutics.

[6]  B. Martin.  Inhibiting vasculogenesis after radiation: a new paradigm to improve local control by radiotherapy. , 2013, Seminars in radiation oncology.

[7]  R. Jain.  Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  R. McLendon,et al.  Glioblastoma Stem Cells Generate Vascular Pericytes to Support Vessel Function and Tumor Growth , 2013, Cell.

[9]  J. Lan,et al.  Ablative Hypofractionated Radiotherapy Normalizes Tumor Vasculature in Lewis Lung Carcinoma Mice Model , 2013, Radiation research.

[10]  M. Andreeff,et al.  Origins of the Tumor Microenvironment: Quantitative Assessment of Adipose-Derived and Bone Marrow–Derived Stroma , 2012, PloS one.

[11]  E. Kleinerman,et al.  SDF-1α Induces PDGF-B Expression and the Differentiation of Bone Marrow Cells into Pericytes , 2011, Molecular Cancer Research.

[12]  C. Betsholtz,et al.  Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. , 2011, Developmental cell.

[13]  E. Kleinerman,et al.  Bone marrow cells participate in tumor vessel formation that supports the growth of Ewing’s sarcoma in the lung , 2011, Angiogenesis.

[14]  M. Andreeff,et al.  Concise Review: Dissecting a Discrepancy in the Literature: Do Mesenchymal Stem Cells Support or Suppress Tumor Growth? , 2010, Stem cells.

[15]  P. V. Van Veldhuizen,et al.  Tumor cell-derived PDGF-B potentiates mouse mesenchymal stem cells-pericytes transition and recruitment through an interaction with NRP-1 , 2010, Molecular Cancer.

[16]  H. Vogel,et al.  Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. , 2010, The Journal of clinical investigation.

[17]  R. Jain.  A new target for tumor therapy. , 2009, The New England journal of medicine.

[18]  T. Lawrence,et al.  Radiation increases invasion of gene-modified mesenchymal stem cells into tumors. , 2009, International journal of radiation oncology, biology, physics.

[19]  J. Vacanti,et al.  Bone marrow Derived Pluripotent Cells are Pericytes which Contribute to Vascularization , 2009, Stem Cell Reviews and Reports.

[20]  Lingli Tu,et al.  Endostar, a recombined humanized endostatin, enhances the radioresponse for human nasopharyngeal carcinoma and human lung adenocarcinoma xenografts in mice , 2009, Cancer science.

[21]  W. Arap,et al.  White adipose tissue cells are recruited by experimental tumors and promote cancer progression in mouse models. , 2009, Cancer research.

[22]  A. Kate Sasser,et al.  Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression , 2009, PloS one.

[23]  Yao‐Hua Song,et al.  Tissue-resident stem cells promote breast cancer growth and metastasis. , 2009, Carcinogenesis.

[24]  C. Chiang,et al.  Radiotherapy Decreases Vascular Density and Causes Hypoxia with Macrophage Aggregation in TRAMP-C1 Prostate Tumors , 2009, Clinical Cancer Research.

[25]  D. Banerjee,et al.  Mesenchymal stem cells: flip side of the coin. , 2009, Cancer research.

[26]  M. Yost,et al.  A three-dimensional model of vasculogenesis. , 2009, Biomaterials.

[27]  A. Caplan.  Why are MSCs therapeutic? New data: new insight , 2009, The Journal of pathology.

[28]  S. Badylak,et al.  A perivascular origin for mesenchymal stem cells in multiple human organs. , 2008, Cell stem cell.

[29]  A. Caplan.  All MSCs are pericytes? , 2008, Cell stem cell.

[30]  Lei Yuan,et al.  Engineering Robust and Functional Vascular Networks In Vivo With Human Adult and Cord Blood–Derived Progenitor Cells , 2008, Circulation research.

[31]  T. Hardingham,et al.  Bone marrow‐derived mesenchymal stem cells express the pericyte marker 3G5 in culture and show enhanced chondrogenesis in hypoxic conditions , 2008, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[32]  S. Vandenberg,et al.  HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. , 2008, Cancer cell.

[33]  W. Woodward,et al.  Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment. , 2007, Cancer research.

[34]  Yoshihiro Takai,et al.  A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancer. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[35]  M. Endres,et al.  Towards in situ tissue repair: Human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2 , 2007, Journal of cellular biochemistry.

[36]  J. Folkman.  Opinion: Angiogenesis: an organizing principle for drug discovery? , 2007, Nature Reviews Drug Discovery.

[37]  C. Belka,et al.  The role of PDGF in radiation oncology , 2007, Radiation oncology.

[38]  Xiaobing Fu,et al.  Adult bone-marrow-derived mesenchymal stem cells contribute to wound healing of skin appendages , 2006, Cell and Tissue Research.

[39]  S. Verma,et al.  Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. , 2006, The Journal of clinical investigation.

[40]  Uwe Mehlhorn,et al.  Basic Fibroblast Growth Factor Controls Migration in Human Mesenchymal Stem Cells , 2006, Stem cells.

[41]  N. Gorin,et al.  Local Irradiation Not Only Induces Homing of Human Mesenchymal Stem Cells at Exposed Sites but Promotes Their Widespread Engraftment to Multiple Organs: A Study of Their Quantitative Distribution After Irradiation Damage , 2006, Stem cells.

[42]  C. Betsholtz,et al.  Pericytes and vascular stability. , 2006, Experimental cell research.

[43]  Z. Werb,et al.  PDGFRβ+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival , 2005, Nature Cell Biology.

[44]  M. Andreeff,et al.  Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. , 2005, Cancer research.

[45]  R. Jain.  Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy , 2005, Science.

[46]  N. Perico,et al.  Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. , 2004, Journal of the American Society of Nephrology : JASN.

[47]  D. Hanahan,et al.  Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. , 2003, The Journal of clinical investigation.

[48]  S. Tyldesley,et al.  Estimating the need for radiotherapy for lung cancer: an evidence-based, epidemiologic approach. , 2001, International journal of radiation oncology, biology, physics.

[49]  R. Weichselbaum,et al.  Blockade of the Vascular Endothelial Growth Factor Stress Response Increases the Antitumor Effects of Ionizing Radiation , 1999 .

[50]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[51]  D. Prockop.  Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues , 1997, Science.

[52]  E. Jaffe,et al.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.

[53]  Lei Deng,et al.  Pericytes: a double-edged sword in cancer therapy. , 2015, Future oncology.

[54]  J. Lan,et al.  Enhanced radioresponse with a novel recombinant human endostatin protein via tumor vasculature remodeling: experimental and clinical evidence. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[55]  Zhongxing Liao,et al.  Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[56]  D. Gisselsson,et al.  Bone marrow multipotent mesenchymal stroma cells act as pericyte-like migratory vehicles in experimental gliomas. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[57]  Merlin Lee,et al.  From bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 23, 2013. For personal use , 2002 .

[58]  M. Pittenger,et al.  Human mesenchymal stem cells: progenitor cells for cartilage, bone, fat and stroma. , 2000, Current topics in microbiology and immunology.